MedTrace Logo

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

NCT06009484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2141

Last updated 2023-08-24

No results posted yet for this study

Summary

Based on data on a cohort of 2,141 patients undergoing elective colonic cancer resection in an ERAS program, the incidence of postoperative thromboembolic events is estimated in patients no receiving prolonged thromboembolic prophylaxis.

Conditions

Interventions

PROCEDURE

Colon resection

Colon cancer resection

Sponsors & Collaborators

  • Bispebjerg Hospital

    collaborator OTHER

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • Hvidovre University Hospital

    collaborator OTHER

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Claus A Bertelsen, Ph.D. · Copenhagen University Hospital - North Zealand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2017-12-31
Completion
2018-03-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06009484 on ClinicalTrials.gov